Pfizer agrees to let other companies make its COVID-19 Pill

by: - November 22, 2021
77 Views   no discussions

Drugmaker Pfizer Inc. has signed a deal with a United Nations- backed group to allow other manufacturers to make its experimental COVID-19, a move that could the treatment available to more than half of the world’s population.

In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based medicines patent pool, which would let generic drug companies produce the pill for the use in 95 countries, making up about 53% of the world’s population.

The deal excludes some large countries that have suffered devastating coronavirus outbreaks. For example, while a Brazilian drug company could get a license to make the pill for export to other countries, the medicine could not be made generically for use in Brazil.

Still, Health officials said the fact that the deal was struck even before Pfizer’s pill has been authorised anywhere, could help to end the pandemic quicker.

Under the terms of the agreement, Pfizer will not receive royalties on sales in low income countries and will waive royalties on sales in all countries covered by the agreement while COVID-19 remains a public emergency.

Earlier this month, Pfizer said its pill cut the risk of hospitalisation and death by nearly 90% in people with mild to moderate coronavirus infections. Independent experts recommended halting the company’s study based on its promising results.